Bliss GVS Pharma 대차 대조표 상태
재무 상태 기준 확인 6/6
Bliss GVS Pharma has a total shareholder equity of ₹10.5B and total debt of ₹832.9M, which brings its debt-to-equity ratio to 7.9%. Its total assets and total liabilities are ₹12.8B and ₹2.3B respectively. Bliss GVS Pharma's EBIT is ₹1.2B making its interest coverage ratio -36.2. It has cash and short-term investments of ₹2.2B.
주요 정보
7.9%
부채 비율
₹832.88m
부채
| 이자 보상 비율 | -36.2x |
| 현금 | ₹2.20b |
| 주식 | ₹10.48b |
| 총 부채 | ₹2.34b |
| 총 자산 | ₹12.83b |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
재무 상태 분석
단기부채: 506197's short term assets (₹8.5B) exceed its short term liabilities (₹1.9B).
장기 부채: 506197's short term assets (₹8.5B) exceed its long term liabilities (₹418.8M).
부채 대 자본 내역 및 분석
부채 수준: 506197 has more cash than its total debt.
부채 감소: 506197's debt to equity ratio has reduced from 12.9% to 7.9% over the past 5 years.
부채 범위: 506197's debt is well covered by operating cash flow (126.1%).
이자 보장: 506197 earns more interest than it pays, so coverage of interest payments is not a concern.